Leadless pacemaker versus transvenous single-chamber pacemaker therapy: A propensity score-matched analysis

This study reveals favorable complication rates for leadless compared to transvenous single-chamber pacing therapy at mid-term follow-up in a propensity score-matched cohort. When including PM advisory-related complications, this advantage is no longer observed.